Andere Sprachen IRADIMED CORPORATION

Aktien

A118V4

US46266A1097

IRMD

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
44,7 ^USD	+1,94 %		+6,78 %	-5,84 %

02.05.	Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024
02.05.	IRADIMED CORPORATION meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M	02.05.
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q1 EPS $0.36	02.05.
IRadimed: Q1 Earnings Snapshot	02.05.
IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2024	02.05.
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share	02.05.
IRADIMED CORPORATION Declares Regular Quarterly Cash Dividend, Payable on May 30, 2024	02.05.
IRADIMED CORPORATION Provides Revenue Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024	02.05.
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd	25.04.
IRadimed Files $75 Million Common Stock Shelf Registration	03.04.
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13.03.
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13.03.
IRadimed: Q4 Earnings Snapshot	08.02.
Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q4 Revenue $17.5M	08.02.
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q4 EPS $0.39	08.02.
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results	08.02.
IRadimed Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08.02.
IRadimed Corporation Provides Revenue Guidance for the First Quarter and Full Year of 2024	08.02.
North American Morning Briefing : S&P 500 to Open -2-	08.02.
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.	01.02.
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue	09.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen IRADIMED CORPORATION

Aktien

A118V4

US46266A1097

IRMD

Andere Sprachen

Filter